compounded semaglutide depression and Depression: What the Science Shows Semaglutide and Depression: What Is

Simple meals to reduce decision fatigue when appetite feels different

Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease

A thorough medical evaluation is necessary to determine if it is appropriate for you

Semaglutide may be an option for adults who struggle with weight loss despite diet and exercise

In 2019 alone, diabetes accounted for 11.3% of global deaths, but in the Middle East, this figure is higher, with diabetes accounting for 16.2% of deaths in the region (Saeedi et al